ERT announced the launch of the Insights Cloud™, a suite of data analytics, visualization, and workflow applications.
ERT announced the launch of the Insights Cloud™, a suite of data analytics, visualization, and workflow applications. EXPERT Central™ - ERT's proprietary Research & Integration platform, includes an eClinical data hub for integrating and harmonizing clinical trials data from any clinical system. The integration framework includes standard adapters to leading electronic data capture (EDC) solutions such as Medidata Rave® and Oracle InForm®, and facilitates the real-time exchange of clinical trials data. This builds on ERT's acquisition of eClinical Insights in 2014.
The ERT Insights Cloud now offers site selection, risk-based management, and enhanced performance measurement.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.